Waegener International AG announces strong participation at the Soccerex Global Convention 2011 in Rio de Janeiro, Brazil.

  • November 10, 2011

Waegener announces first release of the Athlete’s Care cTreatment® Program for maximum performance.

 

Baar (Zug), Switzerland, November 10, 2011 /PR Newswire/ - Waegener congratulates the Soccerex and its organizing committees with an outstanding performance serving the global professional soccer community with these initiatives over the past 16 years.

 

Waegener® is an international medical research and development company predominantly focused on fast track recovery and rehabilitation after traumas and is based in Switzerland. During the last seven years Waegener® developed a range of cTreatments® as a platform to provide specific, protocolled solutions for indications. Waegener®’s strategic research partners experienced cTreatment® over the last two years and concluded that it is unthinkable to continue without these modalities. Our prestigious research partners integrated cTreatment® into their recovery and rehabilitation programs as standard of care. Some of them include Manchester United Football Club, Eindhoven Football Club PSV and Real Madrid CF.

 

The Company underwrites the goals of the Soccerex, catering to the global soccer industry and is a proud exhibitor and participant at the three-day meeting, taking place in Rio de Janeiro, Brazil.

 

Mr. Levi Dewaegenaere, CEO and founder of Waegener: “My personal experience as a professional athlete was the foundation for our Athlete’s Care Program. Professional athlete uptime is a key focus in terms of our research regarding the Athlete’s Care cTreatment® program. We are excited to present our cTreatments® for various indications at Soccerex 2011.”

 

Chief Commercial Officer, Mr. Wout van Loon and co-founder of Waegener continues: “Soccer teams invest significant in their athletes and are continuously looking for ways to maintain or stretch their top performing athletes’ uptime on the field and during practice. Management of sport’s organization experiences day-by-day that fallout of athletes hit their bottom-line dramatically. Their medical staffs are focused on Athlete Care to avoid or to minimize performance decrease situations in their organizations. Athletes know they need additional support as conventional methods do not bring the desired results. Thanks to Waegener’s cTreatment® the athlete experiences fast and efficient rehabilitation and recovery and quick resumption of training schedules.“

 

Waegener® cTreatment® solutions are specifically designed to match the requirements of an individual athlete. Waegener® developed a treatment platform to address the individual needs of an athlete. Waegener offers a complete suite of treatments for all areas of recovery, which can be prescribed by the doctor and / or physical therapist. All treatments support an optimal recovery and prevention process in both acute trauma situations as for chronic pain, pain management and rehabilitation and recovery with regeneration support. cTreatment® thus provides a win-win situation both to the professional soccer club, the athlete, management, owners and the trainer.

###

For more information, please visit www.waegener.com or contact Pieter van der Poel, Marketing Director at pietervdp@waegener.com or via +41 79 903 69 90.

###

Waegener, created in 2003, researches and develops effective treatments to guide and accelerate the natural recovery capacity of the human body after traumas, by applying controlled local thermodynamic energy exchange.

 

Waegener combines pioneering, patented technology and medical research with cTreatments®. Waegener’s cTreatments® focus on orthopedics, traumatology, dental, esthetic surgery, sports rehabilitation and pain management.

 

Headquartered in Baar (Zug), Switzerland, and with subsidiaries in Austria, Belgium and Turkey, Waegener’s employees are dedicated to continuously improving professional sports as well as health care practices. Waegener invests substantially in clinical research and studies, quality and safety, global expansion and the development of new cTreatments®.